↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.0MSold on the market
1Companies
Sep 18, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 202618:57 | Sep 16, 2026 | ROIVRoivant Sciences Ltd. | Director | A · Grant | — | +5,054 | 41,162 | +14% | — | ||
| Sep 17, 202618:42 | Sep 15, 2026 | ROIVRoivant Sciences Ltd. | Director | S · Sell10b5-1 | $39.74 | −5,112 | 36,108 | -12% | −$203K | ||
| Sep 14, 202618:29 | Sep 10, 2026 | ROIVRoivant Sciences Ltd. | Director | F · Tax | $40.94 | −1,743 | 41,220 | -4% | $71K | ||
| Sep 10, 202621:00 | Sep 8, 2026 | ROIVRoivant Sciences Ltd. | Director | S · Sell10b5-1 | $39.90 | −20,000 | 42,963 | -32% | −$798K | ||
| Sep 10, 202621:00 | Sep 8, 2026 | ROIVRoivant Sciences Ltd. | Director | M · Exercise10b5-1 | $8.80 | +20,000 | 62,963 | +47% | $176K |